2 unchanged sentences
Cigna's common stock is listed with, and trades on, the New York Stock Exchange under the symbol "CI".
−Removed: On January 6, 2021 Cigna initiated a quarterly cash dividend and declared the first quarterly cash dividend of $1.00 per share of Cigna common stock to be paid on March 25, 2021 to shareholders of record as of March 10, 2021.
+Added: In 2021, Cigna initiated a quarterly cash dividend and declared quarterly cash dividends of $1.00 per share of Cigna common stock.
Cigna currently intends to pay regular quarterly dividends, with future declarations subject to approval by its Board of Directors and the Board's determination that the declaration of dividends remains in the best interests of Cigna and its shareholders.
1 unchanged sentence
For the years ended December 31, 2020 and 2019, Cigna paid a yearly cash dividend of $0.04 per share of Cigna common stock.
+Added: See Note 8 to the Consolidated Financial Statements for further information on dividend payments.
+Added: For information on securities authorized for issuance under our existing equity compensation plans, see Item 12 under the heading "Security Ownership of Certain Beneficial Owners and Management and Rebated Stockholder Matters."
Issuer Purchases of Equity Securities
1 unchanged sentence
Period Total # of shares purchased (1)
−Removed: Average price paid per share Total # of shares purchased as part of
+Added: Average price paid per share (1)
+Added: Total # of shares purchased as part of
publicly announced program (2)
9 unchanged sentences
Employees tendered 567 shares in October, 2,226 shares in November and 7,528 shares in December 2021.
+Added: Amount purchased also reflects the final delivery of 910,182 shares in November 2021 and 932,888 shares in December 2021 pursuant to the ASR agreements discussed in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2.
+Added: Such repurchases were made pursuant to the Company's share repurchase program described in note (2) of this table.
+Added: Average price paid per share for shares not purchased pursuant to the ASR agreements was $215.20 in November 2021 and $213.17 in December 2021.
(2) Additionally, the Company maintains a share repurchase program authorized by the Board of Directors.
3 unchanged sentences
The program may be suspended or discontinued at any time and does not have an expiration date.
−Removed: In December 2020, the Board increased repurchase authority by an additional $2 billion.
−Removed: From January 1, 2021 through February 24, 2021, the Company repurchased 8.1 million shares for approximately $1.7 billion, leaving repurchase authority at $2.1 billion as of February 24, 2021.
+Added: In February 2022, the Board increased repurchase authority by an additional $2.0 billion.
+Added: Share repurchase authority was $6.0 billion as of February 23, 2022.
(3) Approximate dollar value of shares is as of the last date of the applicable month.
Stock Price Performance Graph
−Removed: The graph below compares the cumulative total shareholder return on our common stock for the five years ended December 31, 2020 with the cumulative total return of the Standard & Poor’s 500 Index, the Standard & Poor’s 500 Health Care Providers & Services Index and the Standard & Poor’s Managed Health Care, Life & Health Insurance Indexes.
+Added: The graph below compares the cumulative total shareholder return on our common stock for the five years ended December 31, 2021 with the cumulative total return of the Standard & Poor's ("S&P") 500 Index and the S&P 500 Health Care Index.
The stock performance shown in the graph is not intended to forecast or be indicative of future performance.
−Removed: With consideration to Cigna's evolved strategy and recent divestiture of the Group Disability and Life business, for future filings we will select to present the S&P 500 Health Care Index as our peer group for this disclosure.
−Removed: Peer indices disclosed in previous filings are included herein for comparison.
−Removed: SELECTED FINANCIAL DATA
−Removed: The selected financial data previously required by Item 301 of Regulation S-K has been omitted in reliance on SEC Release No.
−Removed: 33-10890, Management’s Discussion and Analysis, Selected Financial Data and Supplementary Financial Information.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.